Listar Technical documents and research evidence on COVID-19 por título
Mostrando ítems 773-792 de 1749
-
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Tria
(2020-03-20)Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. We evaluate the role of hydroxychloroquine on respiratory viral loads. Patients and ... -
Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients
(2020-05-08)Background: COVID-19 has rapidly emerged as a pandemic infection that has caused significant mortality and economic losses. Potential therapies and means of prophylaxis against COVID-19 are urgently needed to combat this ... -
Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19
(2020-05-01)Importance: Coronavirus disease 2019 (COVID-19) is a pandemic with no specific drugs and high mortality. The most urgent thing is to find effective treatments. Objective: To determine whether hydroxychloroquine application ... -
Hydroxychloroquine in COVID-19: A systematic review and meta-analysis
(2020-05-20)Abstract Background Hydroxychloroquine is being administered among patients with COVID19 infection in many healthcare systems across the world considering its in vitro effect against the SARS CoV 2 virus. In spite of several ... -
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019
(2020-05-14)Objective To assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19). Design Multicentre, open label, randomised ... -
Hydroxychloroquine safety: A meta-analysis of randomized controlled trials
(2020-07-06)Background: Hydroxychloroquine (HCQ) is currently being examined for COVID-19. No previous meta-analysis has evaluated its side effects versus placebo. We conducted this meta-analysis to compare the safety of HCQ versus ... -
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
(2020-07-03)BACKGROUND Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited. METHODS We conducted a ... -
Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic
(2020-04)Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past seventy years [1]. These agents have attracted intense media attention ... -
Identification of mosquito-borne flavivirus sequences using universal primers and reverse transcription/polymerase chain reaction
(2014)A reverse transcription/polymerase chain reaction (RT/PCR) protocol for the rapid detection and identification of flaviviruses was developed using a set of universal oligonucleotide primers. These primers correspond to ... -
Identification of super-transmitters of SARS-CoV-2
(2020-04-22)A newly emerged coronavirus, SARS-CoV-2, caused severe outbreaks of pneumonia in China in December 2019 and has since spread to various countries around the world. To probe the origin and transmission dynamics of this ... -
Identification of traditional Chinese Medicine syndromes for patients with COVID-19 pneumonia
(2020-03-21)What is this? Early and comprehensive identification of the clinical commonality of COVID is important for early and accurate use of traditional Chinese medicine (TCM). The clinical characteristics and TCM syndrome ... -
Identifying Locations with Possible Undetected Imported Severe Acute Respiratory Syndrome Coronavirus 2 Cases by Using Importation Predictions
(2020-03-24)Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection exported from mainland China could lead to self-sustained outbreaks in other countries. By February 2020, several countries were reporting ... -
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins
(2020-03-26)The ongoing outbreak of viral pneumonia in China and across the world is associated with a new coronavirus, SARS-CoV-2. This outbreak has been tentatively associated with a seafood market in Wuhan, China, where the sale ... -
Imaging and Clinical Features of Patients With 2019 Novel Coronavirus SARS‐CoV‐2: A systematic review and meta‐analysis
(2020-04-03)[Abstract]. Background: Currently, the epidemic of Coronavirus Disease 2019 (COVID‐19) has begun to spread worldwide. We aim to explore reliable evidences for the diagnosis and treatment of the COVID‐19 by analyzing all ... -
Immune response following infection with SARS‐CoV‐2 and other coronaviruses: A rapid review
(2020-09-23)In this review, we systematically searched and summarized the evidence on the immune response and reinfection rate following SARS‐CoV‐2 infection. We also retrieved studies on SARS‐CoV and MERS‐CoV to assess the long‐term ...